4
Changes in Ownership
ALX ONCOLOGY HOLDINGS INC Filed Acc 0000899243-21-013283
President and CEO sold 16,700 shares at an average $68.49 ($1,143,860)
- President and CEO acquired 16,700 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Pons Jaume · President and CEO
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-03-22 | Exercise or conversion : show line 1 in the form | +16,700 | $1.91 | $31,897 | 568,046 | D |
| 2021-03-22 | Sale : show line 2 in the form | −1,200 | $63.79 | $76,545 | 566,846 | D |
| 2021-03-22 | Sale : show line 3 in the form | −900 | $64.98 | $58,486 | 565,946 | D |
| 2021-03-22 | Sale : show line 4 in the form | −600 | $66.33 | $39,795 | 565,346 | D |
| 2021-03-22 | Sale : show line 5 in the form | −1,500 | $67.18 | $100,773 | 563,846 | D |
| 2021-03-22 | Sale : show line 6 in the form | −2,700 | $68.27 | $184,329 | 561,146 | D |
| 2021-03-22 | Sale : show line 7 in the form | −9,200 | $69.77 | $641,857 | 551,946 | D |
| 2021-03-22 | Sale : show line 8 in the form | −600 | $70.12 | $42,075 | 551,346 | D |
| Open-market sales · 16,700 sh · avg $68.49 · $1,143,860 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-03-22 | Exercise or conversion : show line 9 in the form Employee Stock Option (right to buy) | −16,700 | 89,019 | D |
Loading xslF345X03/doc4.xml…